Osmoregulation of plasma vasopressin in myxedema. 1990

Y Iwasaki, and Y Oiso, and K Yamauchi, and K Takatsuki, and K Kondo, and H Hasegawa, and A Tomita
Department of Internal Medicine, Nagoya University School of Medicine, Japan.

We studied osmoregulation of plasma vasopressin (AVP) in eight patients with untreated myxedema due to primary hypothyroidism. All patients had severe thyroid hormone deficiency due to chronic thyroiditis and had been receiving no medication at the time of this study. AVP release was defined by 5% hypertonic saline infusion test in all patients, and urinary diluting capacity was estimated by the iv water-loading tests in five patients. Plasma AVP was measured by sensitive and specific RIA. The mean basal plasma AVP level in the patients (0.5 +/- 0.1 pmol/L) was significantly lower (P less than 0.01) than that in normal adults (2.5 +/- 0.5 pmol/L). During hypertonic saline infusion, the rise in plasma AVP was normal or subnormal in all patients. In two patients who showed mild to moderate hyponatremia in the basal state and mild urinary diluting defect during water loading, plasma AVP was appropriately suppressed in each case. These results indicate that inappropriate elevation of plasma AVP is not common in myxedema, and that impaired water excretion is due mainly to AVP-independent mechanisms.

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009230 Myxedema A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips. Myxedemas
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013963 Thyroid Hormones Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs. Thyroid Hormone,Hormone, Thyroid,Hormones, Thyroid

Related Publications

Y Iwasaki, and Y Oiso, and K Yamauchi, and K Takatsuki, and K Kondo, and H Hasegawa, and A Tomita
January 1986, Journal of cardiovascular pharmacology,
Y Iwasaki, and Y Oiso, and K Yamauchi, and K Takatsuki, and K Kondo, and H Hasegawa, and A Tomita
July 1976, Kidney international,
Y Iwasaki, and Y Oiso, and K Yamauchi, and K Takatsuki, and K Kondo, and H Hasegawa, and A Tomita
November 1990, The American journal of physiology,
Y Iwasaki, and Y Oiso, and K Yamauchi, and K Takatsuki, and K Kondo, and H Hasegawa, and A Tomita
September 2000, Burns : journal of the International Society for Burn Injuries,
Y Iwasaki, and Y Oiso, and K Yamauchi, and K Takatsuki, and K Kondo, and H Hasegawa, and A Tomita
April 1985, Neuroendocrinology,
Y Iwasaki, and Y Oiso, and K Yamauchi, and K Takatsuki, and K Kondo, and H Hasegawa, and A Tomita
April 1987, The American journal of physiology,
Y Iwasaki, and Y Oiso, and K Yamauchi, and K Takatsuki, and K Kondo, and H Hasegawa, and A Tomita
August 1989, The American journal of physiology,
Y Iwasaki, and Y Oiso, and K Yamauchi, and K Takatsuki, and K Kondo, and H Hasegawa, and A Tomita
August 1986, The New England journal of medicine,
Y Iwasaki, and Y Oiso, and K Yamauchi, and K Takatsuki, and K Kondo, and H Hasegawa, and A Tomita
January 2013, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Y Iwasaki, and Y Oiso, and K Yamauchi, and K Takatsuki, and K Kondo, and H Hasegawa, and A Tomita
May 1989, Clinical endocrinology,
Copied contents to your clipboard!